Cancer

AI In Healthcare Market Revenue worth $187.7 Billion by 2030 – Exclusive Study by The Research Insights

CHICAGO, May 21, 2025 /PRNewswire/ -- The global AI In Healthcare Market size is projected to be valued at USD 26.6 Billion in 2024…

7 months ago

Artificial Intelligence in Diagnostics Market Size worth US$ 5.44 billion by 2030 – Exclusive Report by The Research Insights

CHICAGO, May 21, 2025 /PRNewswire/ -- The global Artificial Intelligence in Diagnostics Market Size is projected to be valued at USD 1.97…

7 months ago

Comport Welcomes Michael Volpi as Vice President of Healthcare Technology

RAMSEY, N.J., May 21, 2025 /PRNewswire/ -- Comport Consulting Corp., a trusted partner in delivering innovative technology solutions for the healthcare…

7 months ago

Lexogen Launches miRVEL Discovery – Cutting-edge Small RNA-Seq Library Prep Kit for sRNA Discovery and Biomarker studies

VIENNA, May 21, 2025 /PRNewswire/ -- Lexogen, a leader in RNA sequencing technologies, is excited to announce the launch of…

7 months ago

Freenome Appoints Linh H. Le as Chief Financial Officer

Seasoned diagnostics executive brings expertise in financial strategy and operational infrastructure development across diagnostics and Medtech industries BRISBANE, Calif., May…

7 months ago

Complement 1 Appoints Dr. Christopher Cogle as Chief Medical Officer to Lead Clinical Strategy for Innovative Cancer Lifestyle Platform

Renowned oncologist and translational researcher to spearhead medical strategy as company scales innovative lifestyle modification modelNEW YORK, May 21, 2025…

7 months ago

Bioxytran’s Antiviral Breakthrough Featured in University of Georgia’s $100M HPAI Poultry Innovation Grand Challenge Submission

PHM23 was one of a handful of molecules chosen by the universityBird Flu helping PHM23 gain awareness of broad-spectrum activity…

7 months ago

Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204’s Potential Impact on Colorectal and Lung Cancer

Silexion’s new groundbreaking study explores the potential impact of its next generation RNAI therapeutic candidate beyond pancreatic cancer aiming to…

7 months ago

Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101

Represents significant milestone in the development of KAD101, a novel biologic prolactin receptor antagonist, being initially developed for the treatment…

7 months ago

Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences

MINNEAPOLIS, May 21, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies…

7 months ago